Related Experiment Video
Updated: Jun 14, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study
Larissa Fabritz1,2,3,4,5,6, Christoph Al-Taie1,2,3,6, Katrin Borof2
1University Center of Cardiovascular Science, University Heart and Vascular Center Hamburg, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Insights
Low levels of angiopoietin 2 (ANGPT2), bone morphogenetic protein 10 (BMP10), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) predict sinus rhythm in atrial fibrillation patients. Early rhythm control therapy impacts NT-proBNP
Area of Science:
- Cardiology
- Biomarker Discovery
- Atrial Fibrillation Research
Background:
- Atrial fibrillation (AF) management involves balancing cardiovascular disease processes and rhythm control.
- Predictors for achieving and maintaining sinus rhythm in AF patients are not well-established.
- Understanding these predictors is crucial for optimizing AF treatment strategies.
Purpose of the Study:
- To identify biomarkers that predict sinus rhythm attainment in patients with atrial fibrillation.
- To investigate the interaction between cardiovascular disease biomarkers and early rhythm control therapy on rhythm outcomes.
- To validate predictive biomarker findings in longer-term follow-up and external patient cohorts.
Main Methods:
- Quantified 14 biomarkers related to cardiovascular disease in 1586 AF patients from the EAST-AFNET 4 study.
- Employed mixed logistic regression models incorporating clinical features to assess biomarker associations with sinus rhythm at 12 months.
- Validated results at 24 months and in external datasets, analyzing interactions with early rhythm control.
Main Results:
- Elevated baseline levels of angiopoietin 2 (ANGPT2), bone morphogenetic protein 10 (BMP10), and NT-proBNP were associated with a lower likelihood of sinus rhythm.
- External validation confirmed that low concentrations of ANGPT2, BMP10, and NT-proBNP predict sinus rhythm.
- The predictive value of NT-proBNP for sinus rhythm was reduced in patients receiving early rhythm control therapy (Pinteraction = .033).
Conclusions:
- Low concentrations of ANGPT2, BMP10, and NT-proBNP are reliable indicators for predicting sinus rhythm attainment in AF patients.
- The predictive power of NT-proBNP is diminished when patients receive early rhythm control interventions.
- These findings aid in personalizing AF management by identifying patients likely to achieve sinus rhythm.
Background And Aims:
In patients with atrial fibrillation (AF), recurrent AF and sinus rhythm during follow-up are determined by interactions between cardiovascular disease processes and rhythm control therapy. Predictors of attaining sinus rhythm at follow-up are not well known.
Methods:
To quantify the interaction between cardiovascular disease processes and rhythm outcomes, 14 biomarkers reflecting AF-related cardiovascular disease processes in 1586 patients in the EAST-AFNET 4 biomolecule study (71 years old, 45% women) were quantified at baseline. Mixed logistic regression models including clinical features were constructed for each biomarker. Biomarkers were interrogated for interaction with early rhythm control. Outcome was sinus rhythm at 12 months. Results were validated at 24 months and in external datasets.
Results:
Higher baseline concentrations of three biomarkers were independently associated with a lower chance of sinus rhythm at 12 months: angiopoietin 2 (ANGPT2) (odds ratio [OR] .76 [95% confidence interval .65-.89], P < .001), bone morphogenetic protein 10 (BMP10) (OR .83 [.71-.97], P = .017), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) (OR .73 [.60-.88], P < .001). Analysis of rhythm at 24 months confirmed the results. Early rhythm control interacted with the predictive potential of NT-proBNP (Pinteraction = .033). The predictive effect of NT-proBNP was reduced in patients randomized to early rhythm control (usual care: OR .64 [.51-.80], P < .001; early rhythm control: OR .90 [.69-1.18], P = .453). External validation confirmed that low concentrations of ANGPT2, BMP10, and NT-proBNP predict sinus rhythm during follow-up.
Conclusions:
Low concentrations of ANGPT2, BMP10, and NT-proBNP identify patients with AF who are likely to attain sinus rhythm during follow-up. The predictive ability of NT-proBNP is attenuated in patients receiving rhythm control.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

